HDAC1 and breast cancer: Similarly, inhibition of HDAC1 synergized with anti-PD1 by preventing T cell exhaustion in breast cancer (80), and treatment with HDAC8 inhibitor PCI-34051 combined with anti-PD-L1 induced a robust antitumor effect in liver cancer (26).